Novartis | NVS - 貿易債務者

株価
147.85
毎日の変更
4.86 3.40%
毎月
-3.20%
毎年
32.92%
Q2 予測
142.62




貿易債務者 変化する 日付
AbbVie USD 12.59B 180M 2025-12
Amgen USD 9.57B 1.08B 2025-12
AstraZeneca USD 17.88B 1.17B 2026-03
Bausch Health Companies USD 2.19B 160M 2026-03
Biogen USD 1.79B 76.6M 2026-03
Bristol-Myers Squibb USD 14.52B 91M 2025-12
Canopy Growth CAD 140.42M 113.56M 2025-12
Corcept Therapeutics USD 59.79M 9.84M 2025-12
Drreddys Laboratories INR 1.41B 11.6M 2025-12
Eli Lilly USD 20.16B 697.8M 2025-12
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.94B 178M 2026-03
Glaxosmithkline GBP 10.45B 707.81M 2025-12
J&J USD 21.33B 3.72B 2025-12
Merck USD 11.78B 345M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Novartis USD 12.29B 3.3B 2025-12
Pacira USD 124.07M 8.8M 2025-12
Perrigo USD 612.8M 31.6M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Phibro Animal Health USD 215.87M 2.02M 2025-12
Prestige Brands USD 190.46M 8.54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 482M 85M 2026-03
Sanofi EUR 397M 186.13M 2025-12
Supernus Pharmaceuticals USD 187.8M 16.55M 2025-12
Zoetis USD 1.59B 49M 2025-12